|
|
| Personalized Medicine: Technologies and the Global Market |
|
| Table of Contents Published: 2009/07 Published by: BCC Research |
| Personalized diagnosis and treatment - or personalized medicine - is the most recent trend in the multibillion - dollar molecular diagnostics industry. Pharmaceutical and biotechnology companies are increasingly turning to personalized medicine in order t ... |
| Small Molecule Kinase Inhibitors |
|
| Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc. |
| This report analyzes the Global Market for Small Molecule Kinase Inhibitors in Millions of US$ by the following Product Segments: Gleevec/Glivec, Tarceva, Sutent, Nexavar, Sprycel, Iressa, Tykerb/Tyverb, and Others. ... |
| Strategic Analysis of U.S. Molecular Cytogenetics Markets |
|
| Table of Contents Published: 2009/07 Published by: Frost & Sullivan |
| This research service provides a strategic analysis of the molecular cytogenetics market within the United States. The research service covers market trends, technology trends, competitive structure, market share analysis, and revenue forecasts. The key c ... |
| The SADC Healthcare Regulatory Environment |
|
| Table of Contents Published: 2009/07 Published by: Frost & Sullivan |
| This research service identifies and discusses the regulatory framework (including that of medical waste management and medical insurance) of the Southern African Development Communities (SADC) countries. ... |
| U.S. CRO Markets - Key Therapeutic Areas |
|
| Table of Contents Published: 2009/07 Published by: Frost & Sullivan |
| This research service provides a detailed overview and analysis of key therapeutic areas in the U.S. CRO Market. The research service includes a detailed analysis of market trends, industry challenges and key therapeutic areas. Revenue forecasts from 2010 ... |
| Using Public Relations to Launch, Grow and Extend Your Brands |
|
| Table of Contents Published: 2009/07 Published by: Best Practices, LLC |
| This Best Practices, LLC benchmarking report identifies the most current and effective PR tools and calls-to-action, and explores how top companies align these tactics with each stage of a product' s lifecycle. Pharmaceutical executives and directors can ... |
| 2008/2009 Healthcare Research Review |
|
| Table of Contents Published: 2009/06 Published by: BCC Research |
| BCC Research has provided comprehensive coverage of healthcare technology markets for many years, and we are now in the process of increasing our production of healthcare-related technology market research reports. This review of healthcare research condu ... |
| Biosimilars Series: Forecast Analysis |
|
| Table of Contents Published: 2009/06 Published by: Datamonitor |
| The high cost and utilization of biologic drugs, coupled to the growing need to curb pharmaceutical expenditure, provides considerable momentum to the emerging biosimilars market. With a biosimilar approval pathway in place in Europe and Japan, and immine ... |
| Clinical Bundle |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| The Clinical Bundle includes 4 reports within clinical laboratory analysis. ... |
| Clinical Chemistry Analyzers |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| Clinical chemistry analysis is one of the most important areas within clinical laboratory analysis. The term clinical chemistry usually refers to determining the concentration or activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small mol ... |
| Clinical Immunoanalyzer Markets |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| Clinical immunoanalyzer analysis is one of the most important functions of clinical laboratory analysis. By all accounts, automated immunoassay testing is the most rapidly developing of the traditional clinical laboratory sectors. Clinical immunoanalyzer ... |
| Genetics Bundle |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| The Genetics Bundlel includes 8 reports based on the genetic markets. ... |
| Global In Vitro Diagnostic Market Analysis |
|
| Table of Contents Published: 2009/06 Published by: RNCOS E-Services Pvt. Ltd. |
| The In vitro diagnostics (IVD) market represents one of the most lucrative segments in the global healthcare industry. Various factors, such as increasing prevalence of several chronic and infectious diseases, emerging technologies and increasing patient ... |
| Key Trends Fueling the Boom in Genetic Testing |
|
| Table of Contents Published: 2009/06 Published by: Decision Resources, Inc. |
| Progress aptly describes the expanding field of genetic testing. The field is more than finding linkages of genes with diseases: it encompasses technologies that have made it easier to quickly and more efficiently discover genetic markers that predict dis ... |
| Next-Generation Sequencing: Solving the Genome |
|
| Table of Contents Published: 2009/06 Published by: Insight Pharma Reports |
| Next-generation sequencing (NGS) technologies are advancing in quality and applications diversity at a breathtaking pace. The market is diversifying strongly into labs without previous involvement in sequencing. ... |
| Nucleic Acid Purification Dashboard, Series 2, June 2009 |
|
| Table of Contents Published: 2009/06 Published by: Percepta Associates Inc. |
| Nucleic acid purification is one of the few basic methods ubiquitous among scientists using molecular biology techniques to investigate processes such as gene expression, genetic diversity, protein function and molecular interactions. ... |
| Oncology Partnering Agreements in Pharma, Biotech and Diagnostics |
|
| Table of Contents Published: 2009/06 Published by: CurrentPartnering, a division of Wildwood Ventures Limited |
| The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies.
The report provide ... |
| Pharmacogenomics for Clinical Use and in Drug Development |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the popul ... |
| Pharmacogenomics: Delivering on the Promise |
|
| Table of Contents Published: 2009/06 Published by: Insight Pharma Reports |
| Pharmacogenomics (PGx) is often considered the great new wave in medicine, promising better, safer, and more affordable healthcare. Yet its adoption and widespread use in the clinic is up against some tremendous challenges. ... |
| Point of Care Diagnostic Testing Sector Trends |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| The purpose of this TriMark Publications report is to describe the sector trends within the point of care testing (POCT) diagnostic market. It examines those measurement devices and their reagents and supplies that are utilized in hospitals, clinics, comm ... |
| Point of Care Diagnostic Testing World Markets |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| This TriMark Publications report describes latest developments in the point of care diagnostic testing (POCT) market segment. It examines clinical instruments, devices and reagents and supplies as utilized in near-patient environments like hospital emerge ... |
| Proteomics: Technologies and Global Markets |
|
| Table of Contents Published: 2009/06 Published by: BCC Research |
| The global market for proteomics is expected to increase from $6.7 billion in 2008 to an estimated $7.9 billion in 2009 and $19.4 billion in 2014, for a compound annual growth rate (CAGR) of 19.7%. Proteomics equipment was valued at $4.1 billion in 2008 a ... |
| Stem Cell Markets |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| The purpose of this TriMark Publications report is to describe the specific market segments of the medical research space using stem cells for research and development (R&D) purposes. This study reviews all of the generally accepted analytical methods tha ... |
| Synthetic Biology: Emerging Global Markets |
|
| Table of Contents Published: 2009/06 Published by: BCC Research |
| The biotechnology and pharmaceuticals segment is the second-largest market segment, worth 80.3 million in 2008. This segment is projected to increase at a CAGR of 49.2% to reach $594 million in 2013. ... |
| Therapeutic Monoclonal Antibodies Markets |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| Antibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins. As such, a human-engineered therapeutic monoclonal antibody (mAb) is protein derived from the immune system through re ... |
| Approaches to Reducing Phase II Attrition |
|
| Table of Contents Published: 2009/05 Published by: Insight Pharma Reports |
| Phase II is the critical development stage in which most clinical attrition occurs. This report focuses on approaches to improving R&D productivity in the pharmaceutical and biotechnology industries and considers: ... |
| Asia Pacific Markets for Orthopedic Biomaterials 2009 |
|
| Table of Contents Published: 2009/05 Published by: iData Research Inc. |
| In 2008, the combined Asia Pacific Biomaterials market was worth $810.2 million. This study of the orthopedic biomaterials markets in Australia, Japan, South Korea and China covers autograft, bone graft substitutes (allograft, DBM and synthetic), hyaluron ... |
| Dealmaking and Industry Outlook: Antivirals |
|
| Table of Contents Published: 2009/05 Published by: Decision Resources, Inc. |
| The infamous mutability of viruses has long challenged antiviral drug developers, but complete genome sequences are now known for thousands of viruses, and the viral proteins encoded in these sequences are being used as targets for novel antiviral develop ... |
| European Biological Wastewater Treatment Systems Market |
|
| Table of Contents Published: 2009/05 Published by: Frost & Sullivan |
| This research service looked at the biological wastewater treatment market in Europe. A regional market profile was provided, which included a review of the biological wastewater treatment systems market in each region, analysing the key market forces of ... |
|
|
Top
View Cart
